Vertex Pharmaceuticals (VRTX) Inventory Average (2011 - 2026)

Vertex Pharmaceuticals has reported Inventory Average for 16 years, with the latest figure at $1.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 34.63% year-over-year to $1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (up 34.63% YoY), and the FY2025 full-year result was $1.4 billion, up 48.76% from the prior year.
• Inventory Average for Q1 2026 stood at $1.7 billion, up from $1.7 billion in the prior quarter.
• The five-year high for Inventory Average was $1.7 billion in Q1 2026, with the low at $346.0 million in Q1 2022.
• Average Inventory Average over 5 years is $903.9 million, with a median of $775.9 million recorded in 2024.
• Year-over-year, Inventory Average rose 13.88% in 2022 and soared 70.95% in 2023.
• Tracing VRTX's Inventory Average over 5 years: stood at $424.4 million in 2022, then jumped by 68.18% to $713.8 million in 2023, then jumped by 60.08% to $1.1 billion in 2024, then soared by 45.0% to $1.7 billion in 2025, then advanced by 4.22% to $1.7 billion in 2026.
• The last three Inventory Average figures came in at $1.7 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.

Peer Comparison